0001213900-17-003324.txt : 20170404 0001213900-17-003324.hdr.sgml : 20170404 20170404161640 ACCESSION NUMBER: 0001213900-17-003324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J CENTRAL INDEX KEY: 0001068029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 17738386 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER NAME: FORMER CONFORMED NAME: SCHABER CHRISTOPHER DATE OF NAME CHANGE: 19980811 4 1 f4033117schaber_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2017-03-31 0 0000812796 SOLIGENIX, INC. SNGX 0001068029 SCHABER CHRISTOPHER J 29 EMMONS DRIVE, SUITE C-10 PRINCETON NJ 08540 1 1 0 0 Chairman, CEO and President Option (Right to Buy) 2.67 2017-03-31 4 A 0 50000 0 A 2017-03-31 2027-03-30 Common Stock 50000 50000 D The stock option vested immediately as to 12,500 shares and vests as to the remainder at a rate of 3,125 of the shares on each three (3) month anniversary of March 31, 2017. /s/ Christopher J. Schaber 2017-04-04